Emedgene Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 35

Employees

  • Latest Deal Type
  • M&A

Emedgene General Information

Description

Developer of a genomics intelligence platform designed to interpret genetic tests automatically. The company's platform utilizes an AI engine that performs genomics research through millions of data points from patient cases, databases, and the most recent genomic publications, enabling healthcare professionals to provide personalized care to more patients through higher resolution rates and significantly improved yield.

Contact Information

Website
www.emedgene.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 126 Yigal Alon Street
  • Building A
  • Tel Aviv 6744332
  • Israel
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Acquirer
Illumina
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, TMT, HealthTech, Life Sciences
Corporate Office
  • 126 Yigal Alon Street
  • Building A
  • Tel Aviv 6744332
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emedgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Dec-2021 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
4. Early Stage VC (Series A) 19-Feb-2019 Completed Generating Revenue
3. Grant 01-Oct-2018 Completed Generating Revenue
2. Seed Round 14-Aug-2017 Completed Generating Revenue
1. Accelerator/Incubator 16-Mar-2017 Completed Generating Revenue
To view Emedgene’s complete valuation and funding history, request access »

Emedgene Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
To view Emedgene’s complete cap table history, request access »

Emedgene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genomics intelligence platform designed to interpret genetic tests automatically. The company's platform
Biotechnology
Tel Aviv, Israel
35 As of 2023

Dublin, Ireland
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Emedgene Competitors (10)

One of Emedgene’s 10 competitors is Genuity Science, a Formerly VC-backed company based in Dublin, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genuity Science Formerly VC-backed Dublin, Ireland
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
Fabric Genomics Formerly VC-backed Oakland, CA
Parse Biosciences Formerly VC-backed Seattle, WA
Illumina Formerly VC-backed San Diego, CA
You’re viewing 5 of 10 competitors. Get the full list »

Emedgene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emedgene Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Authority Government
Microsoft for Startups Accelerator/Incubator Minority
Mindset Ventures Venture Capital Minority
Novadea Angel Group Minority
OTV Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Emedgene FAQs

  • When was Emedgene founded?

    Emedgene was founded in 2015.

  • Where is Emedgene headquartered?

    Emedgene is headquartered in Tel Aviv, Israel.

  • What is the size of Emedgene?

    Emedgene has 35 total employees.

  • What industry is Emedgene in?

    Emedgene’s primary industry is Biotechnology.

  • Is Emedgene a private or public company?

    Emedgene is a Private company.

  • What is Emedgene’s current revenue?

    The current revenue for Emedgene is .

  • How much funding has Emedgene raised over time?

    Emedgene has raised $6M.

  • Who are Emedgene’s investors?

    Innovation Authority, Microsoft for Startups, Mindset Ventures, Novadea, and OTV are 5 of 9 investors who have invested in Emedgene.

  • Who are Emedgene’s competitors?

    Genuity Science, Oxford Nanopore Technologies, Fabric Genomics, Parse Biosciences, and Illumina are some of the 10 competitors of Emedgene.

  • When was Emedgene acquired?

    Emedgene was acquired on 01-Dec-2021.

  • Who acquired Emedgene?

    Emedgene was acquired by Illumina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process